OpenSAFELY
Reports

Vaccine Coverage - Second Doses

Description
Weekly* report on COVID-19 vaccination coverage in England focussing on second doses which are due (i.e. where first dose was recorded at least 14 weeks ago). * please note, updates will be limited during August
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
02 Jul 2021
Last updated
02 Aug 2021
Links

OpenSAFELY COVID Vaccine coverage report: Second doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.

The full analytical methods behind the latest results in this report are available here.

Second doses

Please note This report is intended to highlight any differences between subgroups of priority cohorts in receiving second doses, only including those which are due (i.e. where at least 14 weeks has passed since the first dose). It is therefore NOT a comprehensive view of all second doses given to date - to see these figures please refer to the main report.

New: now includes everyone over 18 and a breakdown by brand of first dose

Report last updated 02 Aug 2021

Second dose vaccinations included up to 28 Jul 2021 inclusive

Only persons who had their first dose between the start of the campaign (7 Dec 2020) and 14 weeks ago (21 Apr 2021) are included in the 'due' group.

Contents

Cumulative second dose vaccination figures among:

Back to top

Cumulative second dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,052,448 12,939 1,039,509 98.8 1,096,578
Sex F 610,092 7,910 602,182 98.7 636,335
M 442,351 5,026 437,325 98.9 460,236
Age band 80-84 560,518 6,153 554,365 98.9 582,365
85-89 328,251 4,207 324,044 98.7 341,656
90+ 163,674 2,583 161,091 98.4 172,543
Ethnicity (broad categories) Black 8,162 224 7,938 97.3 10,878
Mixed 2,695 63 2,632 97.7 3,248
Other 5,523 105 5,418 98.1 6,657
South Asian 24,206 693 23,513 97.1 27,881
Unknown 49,210 574 48,636 98.8 57,022
White 962,647 11,277 951,370 98.8 990,892
ethnicity 16 groups African 1,358 42 1,316 96.9 2,072
Bangladeshi or British Bangladeshi 1,050 28 1,022 97.3 1,288
Caribbean 5,838 147 5,691 97.5 7,476
Chinese 1,330 28 1,302 97.9 1,659
Other 4,186 77 4,109 98.2 4,991
Other Asian 3,605 77 3,528 97.9 4,312
British or Mixed British 914,578 10,444 904,134 98.9 938,868
Indian or British Indian 13,412 266 13,146 98.0 14,714
Irish 8,974 147 8,827 98.4 9,450
Other Black 973 35 938 96.4 1,337
Other White 39,067 686 38,381 98.2 42,539
Other mixed 1,001 21 980 97.9 1,148
Pakistani or British Pakistani 6,132 315 5,817 94.9 7,567
Unknown 49,245 574 48,671 98.8 57,057
White + Asian 469 14 455 97.0 532
White + Black African 259 0 259 100.0 364
White + Black Caribbean 959 28 931 97.1 1,197
Index of Multiple Deprivation (quintiles) 1 Most deprived 130,949 2,310 128,639 98.2 140,784
2 173,516 2,569 170,947 98.5 182,749
3 236,068 2,807 233,261 98.8 245,280
4 245,679 2,576 243,103 99.0 253,848
5 Least deprived 247,261 2,429 244,832 99.0 253,918
Unknown 18,970 245 18,725 98.7 19,999
BMI 30+ 185,045 2,044 183,001 98.9 190,330
under 30 867,405 10,899 856,506 98.7 906,241
Chronic cardiac disease no 730,842 8,897 721,945 98.8 765,408
yes 321,601 4,039 317,562 98.7 331,170
Current COPD no 941,297 11,536 929,761 98.8 982,191
yes 111,153 1,407 109,746 98.7 114,380
Dialysis no 1,050,476 12,901 1,037,575 98.8 1,094,541
yes 1,967 35 1,932 98.2 2,030
DMARDs no 1,019,235 12,537 1,006,698 98.8 1,062,621
yes 33,208 406 32,802 98.8 33,950
Dementia no 962,626 11,018 951,608 98.9 1,002,848
yes 89,817 1,918 87,899 97.9 93,723
Psychosis, schizophrenia, or bipolar no 1,044,575 12,740 1,031,835 98.8 1,088,073
yes 7,868 196 7,672 97.5 8,498
Learning disability no 1,051,960 12,922 1,039,038 98.8 1,096,053
yes 483 14 469 97.1 518
SSRI (last 12 months) no 1,010,345 12,334 998,011 98.8 1,053,500
yes 42,098 602 41,496 98.6 43,071
Chemo or radiotherapy no 1,016,162 12,502 1,003,660 98.8 1,059,436
yes 36,281 434 35,847 98.8 37,142
Cancer (lung) no 1,045,219 12,845 1,032,374 98.8 1,089,151
yes 7,224 91 7,133 98.7 7,427
Cancer (excluding lung/haem) no 859,152 10,801 848,351 98.7 898,387
yes 193,291 2,135 191,156 98.9 198,184
Cancer (haematological) no 1,032,619 12,684 1,019,935 98.8 1,076,236
yes 19,824 252 19,572 98.7 20,335
brand of first dose Moderna 7 0 7 100.0 84
Oxford-AZ 285,369 6,013 279,356 97.9 288,274
Pfizer 766,409 6,909 759,500 99.1 767,725
Unknown 658 14 644 97.9 665

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 80+ Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,968,451 17,262 1,951,189 99.1 2,064,062
Sex F 1,034,768 9,387 1,025,381 99.1 1,083,719
M 933,674 7,868 925,806 99.2 980,336
Age band 70-74 1,139,642 9,408 1,130,234 99.2 1,200,437
75-79 828,807 7,854 820,953 99.1 863,618
Ethnicity (broad categories) Black 10,556 280 10,276 97.3 14,686
Mixed 5,299 91 5,208 98.3 6,461
Other 12,306 210 12,096 98.3 15,393
South Asian 47,544 1,092 46,452 97.7 54,817
Unknown 119,595 1,022 118,573 99.1 135,471
White 1,773,142 14,560 1,758,582 99.2 1,837,227
ethnicity 16 groups African 3,458 112 3,346 96.8 5,250
Bangladeshi or British Bangladeshi 1,540 42 1,498 97.3 1,841
Caribbean 5,222 119 5,103 97.7 6,916
Chinese 3,220 49 3,171 98.5 4,081
Other 9,079 161 8,918 98.2 11,305
Other Asian 9,366 161 9,205 98.3 11,144
British or Mixed British 1,686,034 13,489 1,672,545 99.2 1,739,031
Indian or British Indian 27,356 441 26,915 98.4 30,254
Irish 14,252 168 14,084 98.8 15,253
Other Black 1,876 49 1,827 97.4 2,520
Other White 72,842 896 71,946 98.8 82,929
Other mixed 2,128 35 2,093 98.4 2,527
Pakistani or British Pakistani 9,289 462 8,827 95.0 11,578
Unknown 119,602 1,022 118,580 99.1 135,478
White + Asian 1,204 14 1,190 98.8 1,372
White + Black African 812 21 791 97.4 1,078
White + Black Caribbean 1,169 28 1,141 97.6 1,491
Index of Multiple Deprivation (quintiles) 1 Most deprived 249,858 3,234 246,624 98.7 269,927
2 328,706 3,416 325,290 99.0 348,670
3 440,405 3,759 436,646 99.1 460,775
4 458,549 3,339 455,210 99.3 476,868
5 Least deprived 453,887 3,122 450,765 99.3 468,377
Unknown 37,037 385 36,652 99.0 39,431
BMI 30+ 494,375 4,053 490,322 99.2 510,664
under 30 1,474,067 13,202 1,460,865 99.1 1,553,384
Chronic cardiac disease no 1,605,653 13,699 1,591,954 99.1 1,688,512
yes 362,789 3,556 359,233 99.0 375,543
Current COPD no 1,778,308 15,323 1,762,985 99.1 1,867,383
yes 190,134 1,939 188,195 99.0 196,665
Dialysis no 1,964,459 17,199 1,947,260 99.1 2,059,918
yes 3,983 56 3,927 98.6 4,137
DMARDs no 1,897,595 16,632 1,880,963 99.1 1,991,416
yes 70,847 630 70,217 99.1 72,632
Dementia no 1,925,126 16,513 1,908,613 99.1 2,018,793
yes 43,316 742 42,574 98.3 45,262
Psychosis, schizophrenia, or bipolar no 1,949,850 16,870 1,932,980 99.1 2,043,615
yes 18,592 385 18,207 97.9 20,440
Learning disability no 1,965,635 17,192 1,948,443 99.1 2,061,059
yes 2,807 70 2,737 97.5 2,996
SSRI (last 12 months) no 1,867,621 16,261 1,851,360 99.1 1,960,658
yes 100,821 1,001 99,820 99.0 103,397
Chemo or radiotherapy no 1,899,856 16,646 1,883,210 99.1 1,993,656
yes 68,586 609 67,977 99.1 70,399
Cancer (lung) no 1,955,765 17,108 1,938,657 99.1 2,050,986
yes 12,684 154 12,530 98.8 13,062
Cancer (excluding lung/haem) no 1,685,418 14,889 1,670,529 99.1 1,773,016
yes 283,024 2,366 280,658 99.2 291,039
Cancer (haematological) no 1,938,370 16,926 1,921,444 99.1 2,033,094
yes 30,072 336 29,736 98.9 30,961
brand of first dose Moderna 63 7 56 88.9 350
Oxford-AZ 1,181,873 12,054 1,169,819 99.0 1,188,740
Pfizer 785,295 5,166 780,129 99.3 789,754
Unknown 1,211 35 1,176 97.1 1,232

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 70-79 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among care home population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 82,280 2,701 79,579 96.7 86,429
Sex F 58,583 1,778 56,805 97.0 61,299
M 23,695 924 22,771 96.1 25,123
Age band 65-69 4,508 175 4,333 96.1 4,907
70-74 7,077 273 6,804 96.1 7,581
75-79 9,835 392 9,443 96.0 10,402
80-84 14,714 497 14,217 96.6 15,421
85-89 19,481 595 18,886 96.9 20,398
90+ 26,656 756 25,900 97.2 27,720
Ethnicity (broad categories) Black 413 14 399 96.6 490
Mixed 217 14 203 93.5 238
Other 343 14 329 95.9 364
South Asian 616 35 581 94.3 672
Unknown 1,918 70 1,848 96.4 2,065
White 78,771 2,555 76,216 96.8 82,593
Dementia no 36,764 1,232 35,532 96.6 39,102
yes 45,514 1,470 44,044 96.8 47,327
brand of first dose Moderna 0 0 0 NaN 0
Oxford-AZ 60,641 2,128 58,513 96.5 61,355
Pfizer 21,525 567 20,958 97.4 21,595
Unknown 112 7 105 93.8 112

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Care Home Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 726,657 18,917 707,740 97.4 835,072
newly shielded since feb 15 no 453,047 9,807 443,240 97.8 498,897
yes 273,616 9,114 264,502 96.7 336,175
Sex F 404,250 11,102 393,148 97.3 469,091
M 322,392 7,812 314,580 97.6 365,967
Age band 16-29 52,038 2,562 49,476 95.1 70,084
30-39 98,980 4,137 94,843 95.8 127,799
40-49 142,387 4,263 138,124 97.0 166,964
50-59 208,285 4,599 203,686 97.8 230,384
60-69 224,959 3,360 221,599 98.5 239,827
Ethnicity (broad categories) Black 30,282 1,372 28,910 95.5 44,653
Mixed 10,626 476 10,150 95.5 14,427
Other 13,510 427 13,083 96.8 18,270
South Asian 87,094 3,416 83,678 96.1 108,458
Unknown 25,886 504 25,382 98.1 30,422
White 559,244 12,719 546,525 97.7 618,828
Index of Multiple Deprivation (quintiles) 1 Most deprived 201,138 7,224 193,914 96.4 244,447
2 161,630 4,452 157,178 97.2 188,160
3 141,351 3,178 138,173 97.8 159,047
4 113,911 2,191 111,720 98.1 125,097
5 Least deprived 90,580 1,386 89,194 98.5 97,405
Unknown 18,032 490 17,542 97.3 20,902
Learning disability no 702,219 18,221 683,998 97.4 808,129
yes 24,430 700 23,730 97.1 26,936
brand of first dose Moderna 98 14 84 85.7 1,400
Oxford-AZ 472,661 14,938 457,723 96.8 481,243
Pfizer 253,421 3,948 249,473 98.4 269,731
Unknown 469 14 455 97.0 483

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Shielding (Aged 16-69) Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 991,477 8,998 982,479 99.1 1,073,338
Sex F 510,321 4,739 505,582 99.1 549,332
M 481,152 4,263 476,889 99.1 523,999
Ethnicity (broad categories) Black 7,455 203 7,252 97.3 10,864
Mixed 3,885 70 3,815 98.2 4,977
Other 8,932 133 8,799 98.5 12,012
South Asian 36,939 917 36,022 97.5 43,722
Unknown 79,884 826 79,058 99.0 95,165
White 854,378 6,846 847,532 99.2 906,591
ethnicity 16 groups African 2,842 98 2,744 96.6 4,298
Bangladeshi or British Bangladeshi 1,505 35 1,470 97.7 1,764
Caribbean 3,101 63 3,038 98.0 4,501
Chinese 2,870 35 2,835 98.8 3,822
Other 6,069 105 5,964 98.3 8,197
Other Asian 6,790 133 6,657 98.0 8,162
British or Mixed British 808,990 6,237 802,753 99.2 849,044
Indian or British Indian 20,265 329 19,936 98.4 22,995
Irish 5,943 70 5,873 98.8 6,587
Other Black 1,505 35 1,470 97.7 2,058
Other White 39,417 532 38,885 98.7 50,939
Other mixed 1,519 21 1,498 98.6 1,932
Pakistani or British Pakistani 8,379 427 7,952 94.9 10,801
Unknown 79,905 819 79,086 99.0 95,186
White + Asian 875 14 861 98.4 1,022
White + Black African 651 21 630 96.8 896
White + Black Caribbean 847 28 819 96.7 1,120
Index of Multiple Deprivation (quintiles) 1 Most deprived 133,301 2,079 131,222 98.4 151,942
2 170,422 1,806 168,616 98.9 188,006
3 220,843 1,855 218,988 99.2 237,972
4 225,729 1,666 224,063 99.3 240,611
5 Least deprived 220,584 1,393 219,191 99.4 232,197
Unknown 20,580 182 20,398 99.1 22,610
BMI 30+ 254,842 2,121 252,721 99.2 268,541
under 30 736,631 6,874 729,757 99.1 804,797
Chronic cardiac disease no 884,485 7,896 876,589 99.1 959,840
yes 106,988 1,099 105,889 99.0 113,491
Current COPD no 953,204 8,526 944,678 99.1 1,032,612
yes 38,269 476 37,793 98.8 40,719
DMARDs no 972,216 8,841 963,375 99.1 1,053,185
yes 19,257 154 19,103 99.2 20,146
Dementia no 985,964 8,897 977,067 99.1 1,067,388
yes 5,509 98 5,411 98.2 5,943
Psychosis, schizophrenia, or bipolar no 981,358 8,764 972,594 99.1 1,061,634
yes 10,115 238 9,877 97.6 11,697
Learning disability no 989,191 8,932 980,259 99.1 1,070,832
yes 2,282 63 2,219 97.2 2,499
SSRI (last 12 months) no 933,240 8,414 924,826 99.1 1,012,487
yes 58,233 581 57,652 99.0 60,844
Chemo or radiotherapy no 972,447 8,848 963,599 99.1 1,053,458
yes 19,026 147 18,879 99.2 19,873
Cancer (lung) no 989,730 8,981 980,749 99.1 1,071,476
yes 1,743 21 1,722 98.8 1,855
Cancer (excluding lung/haem) no 905,870 8,323 897,547 99.1 983,647
yes 85,603 672 84,931 99.2 89,684
Cancer (haematological) no 988,064 8,960 979,104 99.1 1,069,719
yes 3,409 35 3,374 99.0 3,619
brand of first dose Moderna 42 7 35 83.3 392
Oxford-AZ 657,958 6,769 651,189 99.0 664,258
Pfizer 332,864 2,191 330,673 99.3 337,540
Unknown 609 28 581 95.4 630

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 65-69 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among Learning Disabilities (aged 16-64) population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 66,367 2,357 64,010 96.4 82,789
Sex F 25,872 861 25,011 96.7 31,283
M 40,495 1,498 38,997 96.3 51,506
Age band 16-29 24,948 1,057 23,891 95.8 34,545
30-34 8,498 322 8,176 96.2 10,689
35-39 6,426 231 6,195 96.4 7,721
40-44 5,201 154 5,047 97.0 6,055
45-49 5,355 175 5,180 96.7 6,146
50-54 5,810 154 5,656 97.3 6,482
55-59 5,775 154 5,621 97.3 6,405
60-64 4,347 98 4,249 97.7 4,753
Ethnicity (broad categories) Black 728 49 679 93.3 1,351
Mixed 679 35 644 94.8 1,092
Other 455 21 434 95.4 714
South Asian 3,080 196 2,884 93.6 4,753
Unknown 4,851 133 4,718 97.3 6,335
White 56,567 1,918 54,649 96.6 68,544
brand of first dose Moderna 21 7 14 66.7 322
Oxford-AZ 47,957 2,002 45,955 95.8 49,182
Pfizer 18,347 343 18,004 98.1 21,665
Unknown 35 0 35 100.0 42

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.

Second Doses Overdue Among People With Learning Disabilities (Aged 16-64)

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 60-64 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,152,688 13,614 1,139,074 98.8 1,279,761
Sex F 581,679 7,112 574,567 98.8 637,679
M 570,997 6,496 564,501 98.9 642,075
Ethnicity (broad categories) Black 12,810 434 12,376 96.6 19,621
Mixed 6,055 147 5,908 97.6 8,029
Other 11,781 245 11,536 97.9 16,520
South Asian 43,589 1,071 42,518 97.5 52,829
Unknown 108,542 1,288 107,254 98.8 133,238
White 969,906 10,430 959,476 98.9 1,049,517
ethnicity 16 groups African 5,075 189 4,886 96.3 7,735
Bangladeshi or British Bangladeshi 1,953 49 1,904 97.5 2,296
Caribbean 4,984 161 4,823 96.8 7,805
Chinese 3,612 63 3,549 98.3 4,851
Other 8,169 182 7,987 97.8 11,676
Other Asian 9,030 175 8,855 98.1 11,207
British or Mixed British 913,500 9,436 904,064 99.0 972,293
Indian or British Indian 22,862 399 22,463 98.3 26,551
Irish 5,726 84 5,642 98.5 6,601
Other Black 2,751 84 2,667 96.9 4,081
Other White 50,687 910 49,777 98.2 70,623
Other mixed 2,310 56 2,254 97.6 3,073
Pakistani or British Pakistani 9,751 441 9,310 95.5 12,782
Unknown 108,528 1,288 107,240 98.8 133,224
White + Asian 1,246 21 1,225 98.3 1,477
White + Black African 1,085 28 1,057 97.4 1,498
White + Black Caribbean 1,414 49 1,365 96.5 1,974
Index of Multiple Deprivation (quintiles) 1 Most deprived 165,977 3,304 162,673 98.0 197,358
2 203,231 2,835 200,396 98.6 231,105
3 252,826 2,758 250,068 98.9 278,929
4 257,859 2,373 255,486 99.1 280,049
5 Least deprived 248,717 2,051 246,666 99.2 265,216
Unknown 24,066 294 23,772 98.8 27,090
BMI 30+ 291,662 3,122 288,540 98.9 311,808
under 30 861,021 10,493 850,528 98.8 967,946
Chronic cardiac disease no 1,063,860 12,481 1,051,379 98.8 1,183,896
yes 88,823 1,134 87,689 98.7 95,858
Current COPD no 1,120,651 13,062 1,107,589 98.8 1,244,950
yes 32,032 553 31,479 98.3 34,804
DMARDs no 1,132,761 13,426 1,119,335 98.8 1,258,663
yes 19,922 189 19,733 99.1 21,091
Dementia no 1,149,148 13,538 1,135,610 98.8 1,275,904
yes 3,535 77 3,458 97.8 3,850
Psychosis, schizophrenia, or bipolar no 1,140,314 13,251 1,127,063 98.8 1,264,935
yes 12,369 364 12,005 97.1 14,819
SSRI (last 12 months) no 1,074,031 12,390 1,061,641 98.8 1,196,300
yes 78,652 1,225 77,427 98.4 83,454
Chemo or radiotherapy no 1,135,428 13,440 1,121,988 98.8 1,261,533
yes 17,255 175 17,080 99.0 18,221
Cancer (lung) no 1,151,584 13,601 1,137,983 98.8 1,278,543
yes 1,099 14 1,085 98.7 1,211
Cancer (excluding lung/haem) no 1,083,082 12,887 1,070,195 98.8 1,205,841
yes 69,601 728 68,873 99.0 73,913
Cancer (haematological) no 1,149,575 13,580 1,135,995 98.8 1,276,422
yes 3,108 35 3,073 98.9 3,332
brand of first dose Moderna 91 21 70 76.9 777
Oxford-AZ 855,540 11,088 844,452 98.7 866,341
Pfizer 296,485 2,478 294,007 99.2 304,829
Unknown 567 35 532 93.8 602

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 60-64 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 55-59 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,324,802 19,489 1,305,313 98.5 1,514,751
Sex F 665,910 9,842 656,068 98.5 745,094
M 658,882 9,646 649,236 98.5 769,650
Ethnicity (broad categories) Black 19,418 742 18,676 96.2 31,150
Mixed 8,904 273 8,631 96.9 12,369
Other 15,386 350 15,036 97.7 22,533
South Asian 47,950 1,253 46,697 97.4 60,431
Unknown 127,029 1,820 125,209 98.6 162,834
White 1,106,112 15,050 1,091,062 98.6 1,225,434
ethnicity 16 groups African 8,176 287 7,889 96.5 12,810
Bangladeshi or British Bangladeshi 2,492 63 2,429 97.5 3,024
Caribbean 6,559 301 6,258 95.4 10,997
Chinese 4,550 84 4,466 98.2 6,300
Other 10,836 266 10,570 97.5 16,226
Other Asian 11,732 266 11,466 97.7 15,029
British or Mixed British 1,037,169 13,664 1,023,505 98.7 1,125,824
Indian or British Indian 23,982 448 23,534 98.1 28,658
Irish 6,503 112 6,391 98.3 7,763
Other Black 4,683 161 4,522 96.6 7,343
Other White 62,426 1,281 61,145 97.9 91,840
Other mixed 3,157 98 3,059 96.9 4,396
Pakistani or British Pakistani 9,744 476 9,268 95.1 13,720
Unknown 127,043 1,813 125,230 98.6 162,848
White + Asian 1,827 42 1,785 97.7 2,289
White + Black African 1,617 56 1,561 96.5 2,345
White + Black Caribbean 2,310 77 2,233 96.7 3,339
Index of Multiple Deprivation (quintiles) 1 Most deprived 196,714 4,781 191,933 97.6 244,958
2 233,926 4,088 229,838 98.3 276,255
3 287,133 3,955 283,178 98.6 325,759
4 293,636 3,493 290,143 98.8 326,186
5 Least deprived 286,020 2,744 283,276 99.0 310,254
Unknown 27,363 420 26,943 98.5 31,318
BMI 30+ 322,735 4,186 318,549 98.7 351,547
under 30 1,002,064 15,309 986,755 98.5 1,163,197
Chronic cardiac disease no 1,257,298 18,319 1,238,979 98.5 1,440,306
yes 67,494 1,169 66,325 98.3 74,438
Current COPD no 1,299,732 18,893 1,280,839 98.5 1,486,653
yes 25,060 588 24,472 97.7 28,091
DMARDs no 1,304,772 19,257 1,285,515 98.5 1,493,177
yes 20,027 231 19,796 98.8 21,567
Psychosis, schizophrenia, or bipolar no 1,309,770 18,942 1,290,828 98.6 1,495,844
yes 15,029 546 14,483 96.4 18,900
SSRI (last 12 months) no 1,226,064 17,794 1,208,270 98.5 1,408,337
yes 98,735 1,701 97,034 98.3 106,414
brand of first dose Moderna 203 42 161 79.3 1,512
Oxford-AZ 1,046,962 16,590 1,030,372 98.4 1,065,288
Pfizer 277,123 2,814 274,309 99.0 291,872
Unknown 511 49 462 90.4 553

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 55-59 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 50-54 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,318,181 24,728 1,293,453 98.1 1,567,027
Sex F 666,246 11,970 654,276 98.2 764,834
M 651,931 12,761 639,170 98.0 802,186
Ethnicity (broad categories) Black 22,337 924 21,413 95.9 37,842
Mixed 10,605 315 10,290 97.0 15,470
Other 18,718 518 18,200 97.2 29,029
South Asian 64,743 2,023 62,720 96.9 86,030
Unknown 135,996 2,380 133,616 98.2 180,488
White 1,065,771 18,564 1,047,207 98.3 1,218,154
ethnicity 16 groups African 12,173 483 11,690 96.0 19,985
Bangladeshi or British Bangladeshi 4,004 98 3,906 97.6 4,949
Caribbean 5,075 217 4,858 95.7 9,408
Chinese 4,914 98 4,816 98.0 7,049
Other 13,811 427 13,384 96.9 21,987
Other Asian 15,708 378 15,330 97.6 21,028
British or Mixed British 986,335 16,709 969,626 98.3 1,094,499
Indian or British Indian 28,665 651 28,014 97.7 35,770
Irish 6,419 154 6,265 97.6 7,952
Other Black 5,089 217 4,872 95.7 8,456
Other White 73,038 1,694 71,344 97.7 115,731
Other mixed 3,829 105 3,724 97.3 5,677
Pakistani or British Pakistani 16,366 896 15,470 94.5 24,276
Unknown 135,975 2,387 133,588 98.2 180,467
White + Asian 2,345 49 2,296 97.9 2,982
White + Black African 2,142 70 2,072 96.7 3,325
White + Black Caribbean 2,282 84 2,198 96.3 3,479
Index of Multiple Deprivation (quintiles) 1 Most deprived 204,778 6,503 198,275 96.8 272,433
2 236,418 5,369 231,049 97.7 292,873
3 280,133 4,830 275,303 98.3 329,707
4 286,510 4,172 282,338 98.5 327,033
5 Least deprived 282,751 3,325 279,426 98.8 312,256
Unknown 27,587 532 27,055 98.1 32,718
BMI 30+ 306,796 5,019 301,777 98.4 342,174
under 30 1,011,381 19,712 991,669 98.1 1,224,846
Chronic cardiac disease no 1,275,225 23,723 1,251,502 98.1 1,518,027
yes 42,952 1,008 41,944 97.7 48,986
Current COPD no 1,301,818 24,220 1,277,598 98.1 1,548,022
yes 16,352 511 15,841 96.9 18,998
DMARDs no 1,300,838 24,472 1,276,366 98.1 1,548,036
yes 17,339 259 17,080 98.5 18,984
Psychosis, schizophrenia, or bipolar no 1,303,022 24,059 1,278,963 98.2 1,547,133
yes 15,155 672 14,483 95.6 19,887
SSRI (last 12 months) no 1,212,778 22,435 1,190,343 98.2 1,451,534
yes 105,392 2,289 103,103 97.8 115,486
brand of first dose Moderna 378 70 308 81.5 2,485
Oxford-AZ 1,079,092 21,665 1,057,427 98.0 1,105,174
Pfizer 238,161 2,940 235,221 98.8 260,218
Unknown 539 42 497 92.2 588

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 50-54 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 40-49 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,399,213 58,363 1,340,850 95.8 2,960,818
Sex F 774,018 28,273 745,745 96.3 1,415,736
M 625,184 30,093 595,091 95.2 1,545,040
Ethnicity (broad categories) Black 30,394 1,659 28,735 94.5 89,509
Mixed 15,834 777 15,057 95.1 41,895
Other 27,853 1,400 26,453 95.0 88,109
South Asian 110,649 5,201 105,448 95.3 264,726
Unknown 116,886 5,173 111,713 95.6 325,570
White 1,097,579 44,142 1,053,437 96.0 2,150,967
ethnicity 16 groups African 20,293 1,050 19,243 94.8 56,875
Bangladeshi or British Bangladeshi 8,442 350 8,092 95.9 18,718
Caribbean 4,053 238 3,815 94.1 14,672
Chinese 6,118 301 5,817 95.1 20,615
Other 21,728 1,099 20,629 94.9 67,480
Other Asian 25,515 1,113 24,402 95.6 62,671
British or Mixed British 990,570 39,088 951,482 96.1 1,786,456
Indian or British Indian 48,664 1,701 46,963 96.5 109,382
Irish 6,671 301 6,370 95.5 14,728
Other Black 6,048 371 5,677 93.9 17,948
Other White 100,338 4,746 95,592 95.3 349,790
Other mixed 5,838 294 5,544 95.0 16,611
Pakistani or British Pakistani 28,028 2,037 25,991 92.7 73,948
Unknown 116,907 5,180 111,727 95.6 325,598
White + Asian 3,633 168 3,465 95.4 8,386
White + Black African 3,703 189 3,514 94.9 9,702
White + Black Caribbean 2,660 133 2,527 95.0 7,189
Index of Multiple Deprivation (quintiles) 1 Most deprived 236,845 12,866 223,979 94.6 571,970
2 255,514 11,137 244,377 95.6 577,773
3 286,062 11,676 274,386 95.9 608,496
4 292,936 10,934 282,002 96.3 582,575
5 Least deprived 292,488 10,248 282,240 96.5 546,546
Unknown 35,357 1,498 33,859 95.8 73,416
brand of first dose Moderna 19,544 3,192 16,352 83.7 78,967
Oxford-AZ 1,031,478 49,252 982,226 95.2 1,697,941
Pfizer 347,305 5,824 341,481 98.3 568,442
Unknown 868 98 770 88.7 1,197

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 40-49 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 30-39 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 759,020 32,693 726,327 95.7 3,331,958
Sex F 472,745 19,992 452,753 95.8 1,611,834
M 286,244 12,698 273,546 95.6 1,720,026
Ethnicity (broad categories) Black 16,534 1,085 15,449 93.4 93,821
Mixed 11,347 665 10,682 94.1 60,676
Other 16,877 812 16,065 95.2 119,091
South Asian 70,868 3,647 67,221 94.9 335,706
Unknown 49,287 1,771 47,516 96.4 345,667
White 594,069 24,696 569,373 95.8 2,376,906
ethnicity 16 groups African 11,382 700 10,682 93.8 58,772
Bangladeshi or British Bangladeshi 5,467 280 5,187 94.9 22,463
Caribbean 2,016 161 1,855 92.0 15,743
Chinese 3,164 98 3,066 96.9 30,415
Other 13,706 714 12,992 94.8 88,690
Other Asian 15,680 700 14,980 95.5 75,089
British or Mixed British 534,933 22,232 512,701 95.8 1,855,917
Indian or British Indian 31,248 1,190 30,058 96.2 143,017
Irish 3,465 154 3,311 95.6 16,639
Other Black 3,136 217 2,919 93.1 19,292
Other White 55,657 2,310 53,347 95.8 504,294
Other mixed 4,214 217 3,997 94.9 24,976
Pakistani or British Pakistani 18,480 1,477 17,003 92.0 95,158
Unknown 49,308 1,778 47,530 96.4 345,674
White + Asian 2,583 126 2,457 95.1 11,809
White + Black African 2,100 119 1,981 94.3 10,479
White + Black Caribbean 2,450 203 2,247 91.7 13,426
Index of Multiple Deprivation (quintiles) 1 Most deprived 157,185 9,660 147,525 93.9 747,418
2 154,973 7,273 147,700 95.3 716,919
3 154,560 5,971 148,589 96.1 681,303
4 141,407 4,837 136,570 96.6 589,281
5 Least deprived 121,345 3,738 117,607 96.9 478,982
Unknown 29,519 1,211 28,308 95.9 117,957
brand of first dose Moderna 469 84 385 82.1 131,971
Oxford-AZ 487,683 25,690 461,993 94.7 573,755
Pfizer 270,298 6,839 263,459 97.5 1,533,231
Unknown 546 77 469 85.9 1,316

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 30-39 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 18-29 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 571,949 28,614 543,335 95.0 3,478,972
Sex F 368,683 18,312 350,371 95.0 1,723,029
M 203,210 10,297 192,913 94.9 1,755,719
Ethnicity (broad categories) Black 9,310 903 8,407 90.3 99,239
Mixed 9,737 623 9,114 93.6 74,424
Other 11,207 651 10,556 94.2 137,116
South Asian 45,143 2,877 42,266 93.6 289,401
Unknown 64,309 2,303 62,006 96.4 567,014
White 432,194 21,259 410,935 95.1 2,311,554
ethnicity 16 groups African 5,845 567 5,278 90.3 59,486
Bangladeshi or British Bangladeshi 3,752 266 3,486 92.9 22,589
Caribbean 1,316 140 1,176 89.4 16,394
Chinese 2,513 84 2,429 96.7 54,747
Other 8,708 567 8,141 93.5 82,376
Other Asian 9,842 553 9,289 94.4 66,381
British or Mixed British 401,219 19,593 381,626 95.1 1,928,801
Indian or British Indian 18,928 840 18,088 95.6 105,889
Irish 2,191 119 2,072 94.6 12,621
Other Black 2,149 196 1,953 90.9 23,359
Other White 28,784 1,547 27,237 94.6 370,139
Other mixed 3,423 217 3,206 93.7 28,189
Pakistani or British Pakistani 12,614 1,218 11,396 90.3 94,549
Unknown 64,302 2,303 61,999 96.4 566,993
White + Asian 2,576 119 2,457 95.4 16,135
White + Black African 1,358 91 1,267 93.3 11,816
White + Black Caribbean 2,380 196 2,184 91.8 18,277
Index of Multiple Deprivation (quintiles) 1 Most deprived 114,317 8,309 106,008 92.7 787,500
2 117,271 6,419 110,852 94.5 744,051
3 118,391 5,390 113,001 95.4 705,726
4 107,233 4,200 103,033 96.1 612,080
5 Least deprived 93,569 3,234 90,335 96.5 518,644
Unknown 21,112 1,057 20,055 95.0 110,747
brand of first dose Moderna 798 259 539 67.5 153,531
Oxford-AZ 355,719 20,979 334,740 94.1 366,464
Pfizer 214,949 7,301 207,648 96.6 1,632,687
Unknown 427 70 357 83.6 917

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 18-29 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Vaccine Coverage - Second Doses

Description
Weekly* report on COVID-19 vaccination coverage in England focussing on second doses which are due (i.e. where first dose was recorded at least 14 weeks ago). * please note, updates will be limited during August
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
02 Jul 2021
Last updated
02 Aug 2021
Links

OpenSAFELY COVID Vaccine coverage report: Second doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of January 13th) in our preprint paper available here.

The full analytical methods behind the latest results in this report are available here.

Second doses

Please note This report is intended to highlight any differences between subgroups of priority cohorts in receiving second doses, only including those which are due (i.e. where at least 14 weeks has passed since the first dose). It is therefore NOT a comprehensive view of all second doses given to date - to see these figures please refer to the main report.

New: now includes everyone over 18 and a breakdown by brand of first dose

Report last updated 02 Aug 2021

Second dose vaccinations included up to 28 Jul 2021 inclusive

Only persons who had their first dose between the start of the campaign (7 Dec 2020) and 14 weeks ago (21 Apr 2021) are included in the 'due' group.

Contents

Cumulative second dose vaccination figures among:

Back to top

Cumulative second dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,052,448 12,939 1,039,509 98.8 1,096,578
Sex F 610,092 7,910 602,182 98.7 636,335
M 442,351 5,026 437,325 98.9 460,236
Age band 80-84 560,518 6,153 554,365 98.9 582,365
85-89 328,251 4,207 324,044 98.7 341,656
90+ 163,674 2,583 161,091 98.4 172,543
Ethnicity (broad categories) Black 8,162 224 7,938 97.3 10,878
Mixed 2,695 63 2,632 97.7 3,248
Other 5,523 105 5,418 98.1 6,657
South Asian 24,206 693 23,513 97.1 27,881
Unknown 49,210 574 48,636 98.8 57,022
White 962,647 11,277 951,370 98.8 990,892
ethnicity 16 groups African 1,358 42 1,316 96.9 2,072
Bangladeshi or British Bangladeshi 1,050 28 1,022 97.3 1,288
Caribbean 5,838 147 5,691 97.5 7,476
Chinese 1,330 28 1,302 97.9 1,659
Other 4,186 77 4,109 98.2 4,991
Other Asian 3,605 77 3,528 97.9 4,312
British or Mixed British 914,578 10,444 904,134 98.9 938,868
Indian or British Indian 13,412 266 13,146 98.0 14,714
Irish 8,974 147 8,827 98.4 9,450
Other Black 973 35 938 96.4 1,337
Other White 39,067 686 38,381 98.2 42,539
Other mixed 1,001 21 980 97.9 1,148
Pakistani or British Pakistani 6,132 315 5,817 94.9 7,567
Unknown 49,245 574 48,671 98.8 57,057
White + Asian 469 14 455 97.0 532
White + Black African 259 0 259 100.0 364
White + Black Caribbean 959 28 931 97.1 1,197
Index of Multiple Deprivation (quintiles) 1 Most deprived 130,949 2,310 128,639 98.2 140,784
2 173,516 2,569 170,947 98.5 182,749
3 236,068 2,807 233,261 98.8 245,280
4 245,679 2,576 243,103 99.0 253,848
5 Least deprived 247,261 2,429 244,832 99.0 253,918
Unknown 18,970 245 18,725 98.7 19,999
BMI 30+ 185,045 2,044 183,001 98.9 190,330
under 30 867,405 10,899 856,506 98.7 906,241
Chronic cardiac disease no 730,842 8,897 721,945 98.8 765,408
yes 321,601 4,039 317,562 98.7 331,170
Current COPD no 941,297 11,536 929,761 98.8 982,191
yes 111,153 1,407 109,746 98.7 114,380
Dialysis no 1,050,476 12,901 1,037,575 98.8 1,094,541
yes 1,967 35 1,932 98.2 2,030
DMARDs no 1,019,235 12,537 1,006,698 98.8 1,062,621
yes 33,208 406 32,802 98.8 33,950
Dementia no 962,626 11,018 951,608 98.9 1,002,848
yes 89,817 1,918 87,899 97.9 93,723
Psychosis, schizophrenia, or bipolar no 1,044,575 12,740 1,031,835 98.8 1,088,073
yes 7,868 196 7,672 97.5 8,498
Learning disability no 1,051,960 12,922 1,039,038 98.8 1,096,053
yes 483 14 469 97.1 518
SSRI (last 12 months) no 1,010,345 12,334 998,011 98.8 1,053,500
yes 42,098 602 41,496 98.6 43,071
Chemo or radiotherapy no 1,016,162 12,502 1,003,660 98.8 1,059,436
yes 36,281 434 35,847 98.8 37,142
Cancer (lung) no 1,045,219 12,845 1,032,374 98.8 1,089,151
yes 7,224 91 7,133 98.7 7,427
Cancer (excluding lung/haem) no 859,152 10,801 848,351 98.7 898,387
yes 193,291 2,135 191,156 98.9 198,184
Cancer (haematological) no 1,032,619 12,684 1,019,935 98.8 1,076,236
yes 19,824 252 19,572 98.7 20,335
brand of first dose Moderna 7 0 7 100.0 84
Oxford-AZ 285,369 6,013 279,356 97.9 288,274
Pfizer 766,409 6,909 759,500 99.1 767,725
Unknown 658 14 644 97.9 665

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 80+ Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,968,451 17,262 1,951,189 99.1 2,064,062
Sex F 1,034,768 9,387 1,025,381 99.1 1,083,719
M 933,674 7,868 925,806 99.2 980,336
Age band 70-74 1,139,642 9,408 1,130,234 99.2 1,200,437
75-79 828,807 7,854 820,953 99.1 863,618
Ethnicity (broad categories) Black 10,556 280 10,276 97.3 14,686
Mixed 5,299 91 5,208 98.3 6,461
Other 12,306 210 12,096 98.3 15,393
South Asian 47,544 1,092 46,452 97.7 54,817
Unknown 119,595 1,022 118,573 99.1 135,471
White 1,773,142 14,560 1,758,582 99.2 1,837,227
ethnicity 16 groups African 3,458 112 3,346 96.8 5,250
Bangladeshi or British Bangladeshi 1,540 42 1,498 97.3 1,841
Caribbean 5,222 119 5,103 97.7 6,916
Chinese 3,220 49 3,171 98.5 4,081
Other 9,079 161 8,918 98.2 11,305
Other Asian 9,366 161 9,205 98.3 11,144
British or Mixed British 1,686,034 13,489 1,672,545 99.2 1,739,031
Indian or British Indian 27,356 441 26,915 98.4 30,254
Irish 14,252 168 14,084 98.8 15,253
Other Black 1,876 49 1,827 97.4 2,520
Other White 72,842 896 71,946 98.8 82,929
Other mixed 2,128 35 2,093 98.4 2,527
Pakistani or British Pakistani 9,289 462 8,827 95.0 11,578
Unknown 119,602 1,022 118,580 99.1 135,478
White + Asian 1,204 14 1,190 98.8 1,372
White + Black African 812 21 791 97.4 1,078
White + Black Caribbean 1,169 28 1,141 97.6 1,491
Index of Multiple Deprivation (quintiles) 1 Most deprived 249,858 3,234 246,624 98.7 269,927
2 328,706 3,416 325,290 99.0 348,670
3 440,405 3,759 436,646 99.1 460,775
4 458,549 3,339 455,210 99.3 476,868
5 Least deprived 453,887 3,122 450,765 99.3 468,377
Unknown 37,037 385 36,652 99.0 39,431
BMI 30+ 494,375 4,053 490,322 99.2 510,664
under 30 1,474,067 13,202 1,460,865 99.1 1,553,384
Chronic cardiac disease no 1,605,653 13,699 1,591,954 99.1 1,688,512
yes 362,789 3,556 359,233 99.0 375,543
Current COPD no 1,778,308 15,323 1,762,985 99.1 1,867,383
yes 190,134 1,939 188,195 99.0 196,665
Dialysis no 1,964,459 17,199 1,947,260 99.1 2,059,918
yes 3,983 56 3,927 98.6 4,137
DMARDs no 1,897,595 16,632 1,880,963 99.1 1,991,416
yes 70,847 630 70,217 99.1 72,632
Dementia no 1,925,126 16,513 1,908,613 99.1 2,018,793
yes 43,316 742 42,574 98.3 45,262
Psychosis, schizophrenia, or bipolar no 1,949,850 16,870 1,932,980 99.1 2,043,615
yes 18,592 385 18,207 97.9 20,440
Learning disability no 1,965,635 17,192 1,948,443 99.1 2,061,059
yes 2,807 70 2,737 97.5 2,996
SSRI (last 12 months) no 1,867,621 16,261 1,851,360 99.1 1,960,658
yes 100,821 1,001 99,820 99.0 103,397
Chemo or radiotherapy no 1,899,856 16,646 1,883,210 99.1 1,993,656
yes 68,586 609 67,977 99.1 70,399
Cancer (lung) no 1,955,765 17,108 1,938,657 99.1 2,050,986
yes 12,684 154 12,530 98.8 13,062
Cancer (excluding lung/haem) no 1,685,418 14,889 1,670,529 99.1 1,773,016
yes 283,024 2,366 280,658 99.2 291,039
Cancer (haematological) no 1,938,370 16,926 1,921,444 99.1 2,033,094
yes 30,072 336 29,736 98.9 30,961
brand of first dose Moderna 63 7 56 88.9 350
Oxford-AZ 1,181,873 12,054 1,169,819 99.0 1,188,740
Pfizer 785,295 5,166 780,129 99.3 789,754
Unknown 1,211 35 1,176 97.1 1,232

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 70-79 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among care home population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 82,280 2,701 79,579 96.7 86,429
Sex F 58,583 1,778 56,805 97.0 61,299
M 23,695 924 22,771 96.1 25,123
Age band 65-69 4,508 175 4,333 96.1 4,907
70-74 7,077 273 6,804 96.1 7,581
75-79 9,835 392 9,443 96.0 10,402
80-84 14,714 497 14,217 96.6 15,421
85-89 19,481 595 18,886 96.9 20,398
90+ 26,656 756 25,900 97.2 27,720
Ethnicity (broad categories) Black 413 14 399 96.6 490
Mixed 217 14 203 93.5 238
Other 343 14 329 95.9 364
South Asian 616 35 581 94.3 672
Unknown 1,918 70 1,848 96.4 2,065
White 78,771 2,555 76,216 96.8 82,593
Dementia no 36,764 1,232 35,532 96.6 39,102
yes 45,514 1,470 44,044 96.8 47,327
brand of first dose Moderna 0 0 0 NaN 0
Oxford-AZ 60,641 2,128 58,513 96.5 61,355
Pfizer 21,525 567 20,958 97.4 21,595
Unknown 112 7 105 93.8 112

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Care Home Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 726,657 18,917 707,740 97.4 835,072
newly shielded since feb 15 no 453,047 9,807 443,240 97.8 498,897
yes 273,616 9,114 264,502 96.7 336,175
Sex F 404,250 11,102 393,148 97.3 469,091
M 322,392 7,812 314,580 97.6 365,967
Age band 16-29 52,038 2,562 49,476 95.1 70,084
30-39 98,980 4,137 94,843 95.8 127,799
40-49 142,387 4,263 138,124 97.0 166,964
50-59 208,285 4,599 203,686 97.8 230,384
60-69 224,959 3,360 221,599 98.5 239,827
Ethnicity (broad categories) Black 30,282 1,372 28,910 95.5 44,653
Mixed 10,626 476 10,150 95.5 14,427
Other 13,510 427 13,083 96.8 18,270
South Asian 87,094 3,416 83,678 96.1 108,458
Unknown 25,886 504 25,382 98.1 30,422
White 559,244 12,719 546,525 97.7 618,828
Index of Multiple Deprivation (quintiles) 1 Most deprived 201,138 7,224 193,914 96.4 244,447
2 161,630 4,452 157,178 97.2 188,160
3 141,351 3,178 138,173 97.8 159,047
4 113,911 2,191 111,720 98.1 125,097
5 Least deprived 90,580 1,386 89,194 98.5 97,405
Unknown 18,032 490 17,542 97.3 20,902
Learning disability no 702,219 18,221 683,998 97.4 808,129
yes 24,430 700 23,730 97.1 26,936
brand of first dose Moderna 98 14 84 85.7 1,400
Oxford-AZ 472,661 14,938 457,723 96.8 481,243
Pfizer 253,421 3,948 249,473 98.4 269,731
Unknown 469 14 455 97.0 483

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Shielding (Aged 16-69) Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Back to top

Cumulative second dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Second Doses due at 28 Jul (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 991,477 8,998 982,479 99.1 1,073,338
Sex F 510,321 4,739 505,582 99.1 549,332
M 481,152 4,263 476,889 99.1 523,999
Ethnicity (broad categories) Black 7,455 203 7,252 97.3 10,864
Mixed 3,885 70 3,815 98.2 4,977
Other 8,932 133 8,799 98.5 12,012
South Asian 36,939 917 36,022 97.5 43,722
Unknown 79,884 826 79,058 99.0 95,165
White 854,378 6,846 847,532 99.2 906,591
ethnicity 16 groups African 2,842 98 2,744 96.6 4,298
Bangladeshi or British Bangladeshi 1,505 35 1,470 97.7 1,764
Caribbean 3,101 63 3,038 98.0 4,501
Chinese 2,870 35 2,835 98.8 3,822
Other 6,069 105 5,964 98.3 8,197
Other Asian 6,790 133 6,657 98.0 8,162
British or Mixed British 808,990 6,237 802,753 99.2 849,044
Indian or British Indian 20,265 329 19,936 98.4 22,995
Irish 5,943 70 5,873 98.8 6,587
Other Black 1,505 35 1,470 97.7 2,058
Other White 39,417 532 38,885 98.7 50,939
Other mixed 1,519 21 1,498 98.6 1,932
Pakistani or British Pakistani 8,379 427 7,952 94.9 10,801
Unknown 79,905 819 79,086 99.0 95,186
White + Asian 875 14 861 98.4 1,022
White + Black African 651 21 630 96.8 896
White + Black Caribbean 847 28 819 96.7 1,120
Index of Multiple Deprivation (quintiles) 1 Most deprived 133,301 2,079 131,222 98.4 151,942
2 170,422 1,806 168,616 98.9 188,006
3 220,843 1,855 218,988 99.2 237,972
4 225,729 1,666 224,063 99.3 240,611
5 Least deprived 220,584 1,393 219,191 99.4 232,197
Unknown 20,580 182 20,398 99.1 22,610
BMI 30+ 254,842 2,121 252,721 99.2 268,541
under 30 736,631 6,874 729,757 99.1 804,797
Chronic cardiac disease no 884,485 7,896 876,589 99.1 959,840
yes 106,988 1,099 105,889 99.0 113,491
Current COPD no 953,204 8,526 944,678 99.1 1,032,612
yes 38,269 476 37,793 98.8 40,719
DMARDs no 972,216 8,841 963,375 99.1 1,053,185
yes 19,257 154 19,103 99.2 20,146
Dementia no 985,964 8,897 977,067 99.1 1,067,388
yes 5,509 98 5,411 98.2 5,943
Psychosis, schizophrenia, or bipolar no 981,358 8,764 972,594 99.1 1,061,634
yes 10,115 238 9,877 97.6 11,697
Learning disability no 989,191 8,932 980,259 99.1 1,070,832
yes 2,282 63 2,219 97.2 2,499
SSRI (last 12 months) no 933,240 8,414 924,826 99.1 1,012,487
yes 58,233 581 57,652 99.0 60,844
Chemo or radiotherapy no 972,447 8,848 963,599 99.1 1,053,458
yes 19,026 147 18,879 99.2 19,873
Cancer (lung) no 989,730 8,981 980,749 99.1 1,071,476
yes 1,743 21 1,722 98.8 1,855
Cancer (excluding lung/haem) no 905,870 8,323 897,547 99.1 983,647
yes 85,603 672 84,931 99.2 89,684
Cancer (haematological) no 988,064 8,960 979,104 99.1 1,069,719
yes 3,409 35 3,374 99.0 3,619
brand of first dose Moderna 42 7 35 83.3 392
Oxford-AZ 657,958 6,769 651,189 99.0 664,258
Pfizer 332,864 2,191 330,673 99.3 337,540
Unknown 609 28 581 95.4 630

Footnotes:

  • Patient counts rounded to the nearest 7
  • Only persons who are currently registered and had their fist dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.

Second Doses Overdue Among 65-69 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding